Ocular inserter

Latest EyePoint Pharmaceuticals US, Inc. Patents:

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a first perspective view of a first embodiment of an ocular inserter showing our new design;

FIG. 2 is a second perspective view thereof;

FIG. 3 is a left side view thereof;

FIG. 4 is a top view thereof;

FIG. 5 is a right side view thereof;

FIG. 6 is a bottom view thereof;

FIG. 7 is a front view thereof; and,

FIG. 8 is a rear view thereof.

The broken line showing of parts of the drawings is included for the purpose of illustrating use and environment and forms no part of the claimed design.

Claims

The ornamental design for an ocular inserter, as shown and described.

Referenced Cited
U.S. Patent Documents
3094121 June 1963 Blumenstein et al.
3483810 December 1969 Peters
4105030 August 8, 1978 Kercso
4810244 March 7, 1989 Allen
4820267 April 11, 1989 Harman
5057082 October 15, 1991 Burchette, Jr.
5250026 October 5, 1993 Ehrlich et al.
5273532 December 28, 1993 Niezink et al.
5284479 February 8, 1994 de Jong
5370630 December 6, 1994 Smidebush et al.
5792099 August 11, 1998 DeCamp et al.
5997500 December 7, 1999 Cook
6001089 December 14, 1999 Burroughs
6007515 December 28, 1999 Epstein
D424197 May 2, 2000 Sydlowski
6645192 November 11, 2003 Kenison
7090681 August 15, 2006 Weber et al.
7326185 February 5, 2008 Brand
7468065 December 23, 2008 Weber et al.
7736330 June 15, 2010 Bardy
7798988 September 21, 2010 Aubert et al.
7976490 July 12, 2011 Lawler et al.
D653329 January 31, 2012 Lee-Sepsick
8131346 March 6, 2012 Chesbrough et al.
D681808 May 7, 2013 Holaschke
8663162 March 4, 2014 Bunting
8790293 July 29, 2014 Nazzaro
8945086 February 3, 2015 Becker
8968236 March 3, 2015 Jennings
20030004457 January 2, 2003 Andersson
20030093084 May 15, 2003 Nissan et al.
20040199140 October 7, 2004 Rue et al.
20040230183 November 18, 2004 Breegi et al.
20040243101 December 2, 2004 Gillis
20040260300 December 23, 2004 Gorensek et al.
20060111605 May 25, 2006 Larsen et al.
20060235430 October 19, 2006 Le et al.
20070073248 March 29, 2007 Moenning
20070073265 March 29, 2007 Rue et al.
20070191863 August 16, 2007 De Juan et al.
20080195135 August 14, 2008 Attinger
20080281292 November 13, 2008 Hickingbotham et al.
20090281520 November 12, 2009 Highley et al.
20090299298 December 3, 2009 Bussmann
20100234817 September 16, 2010 Nazzaro et al.
20120016572 January 19, 2012 Maas et al.
20120041369 February 16, 2012 Becker
20120165723 June 28, 2012 Horvath et al.
Foreign Patent Documents
101596337 December 2009 CN
10 2008 006 602 July 2009 DE
0239244 September 1987 EP
03596162 May 1994 EP
0639387 February 1995 EP
2001-502937 March 2001 JP
2003-509082 March 2003 JP
2005-533619 November 2005 JP
2006-320736 November 2006 JP
2006-525953 November 2006 JP
2008-508916 March 2008 JP
1994/011042 May 1994 WO
1999/053991 October 1999 WO
2004/026106 April 2004 WO
WO-2005/053774 June 2005 WO
2007/142890 December 2007 WO
2008/033426 March 2008 WO
2008/070402 June 2008 WO
2008/088623 July 2008 WO
Patent History
Patent number: D851755
Type: Grant
Filed: Oct 22, 2015
Date of Patent: Jun 18, 2019
Assignee: EyePoint Pharmaceuticals US, Inc. (Watertown, MA)
Inventors: Martin Nazzaro (Quincy, MA), Josh York (Ipswich, MA), Ron Leblanc (Hopedale, MA)
Primary Examiner: David G Muller
Application Number: 29/543,267